Both nonneoplastic colon epithelium and colon carcinoma cells in situ are continuously exposed to lipopolysaccharide (LPS). Few reports have addressed possible direct eects of LPS in promotion of colon carcinoma and underlying mechanisms. We found evidence that LPS directly stimulated growth of the human colon carcinoma cell line CE-1 through an increase in the production of prostaglandin E 2 (PGE 2 ) as a result of cyclo-oxygenase-2 (COX-2) expression. LPS induced signi®cant increases in PGE 2 production in CE-1 cells, which were found to express a high-anity LPS receptor, CD14. Positive correlations were found between PGE 2 production and activation of nuclear factor (NF)-kB as well as expression of both COX-2 mRNA and protein in LPSstimulated CE-1 cells. When CE-1 cells were exposed to exogenous PGE 2 , DNA synthesis increased. These results indicate that LPS may stimulate DNA synthesis in certain colon carcinoma cells as a result of PGE 2 production involving increased COX-2 expression that might result in turn from activation of NF-kB by LPS. Further investigation of the pathways mediating LPSinduced stimulation of colon carcinoma cells may provide insights into LPS eects in in vivo tumor biology.
Introduction
LPS is released from the surface of the cell membrane of Gram-negative bacteria, triggering a potent generalized in¯ammatory response when large amounts enter the circulation, such as during endotoxemia (Mayeux, 1997) . Several cell types including macrophages and endothelial cells, have a high-anity receptor for LPS, i.e., CD14 (Mayeux, 1997; Wright et al., 1990) ; LPS has been shown to have biologic eects on these cell types (Lee et al., 1992) . Since the colon contains large numbers of Gram-negative bacteria, colonic epithelial cells are heavily exposed to LPS, as are cells of carcinomas developing at that site. However, few studies have examined direct interactions between LPS and colon carcinoma cells. Recently several lines of evidence have suggested that LPS may directly aect certain human epithelial cells. For example, LPS derived from Pseudomonous aeruginosa has been shown to induce human tracheal epithelial cells to express an antibiotic peptide gene (Diamond et al., 1996) . LPS derived from Helicobacter pylori or Escherichia coli has been shown to induce IL-8 production by gastrointestinal cell lines (Kirkland et al., 1997) . The mechanisms by which LPS activates epithelial cells are not clear.
PGs are produced by several types of cells including LPS-stimulated macrophages, and also are known to be produced by certain carcinoma cells. Previous studies have suggested that PGs may play a role in the development of colon carcinoma, given that tumor cells and tumor-related macrophages produce more PGs than do normal cells (Maxwell et al., 1990; Rigas et al., 1993) . PGE 2 has been shown to inhibit apoptosis in colon carcinoma (Sheng et al., 1998) , and also is known to be a potent inhibitor of physiologic T lymphocyte proliferation (Mastino et al., 1993) . Thus PGE 2 may be a critical asset to colon carcinoma cells in terms of escaping host immunity. PG endoperoxide synthase, known as COX, is a key enzyme of the biosynthesis of prostanoids such as PG and thromboxane. Two distinct COX isozymes, constitutive COX-1 and inducible COX-2, are encoded by separate genes. COX-2 is selectively expressed in response to in¯am-matory stimuli including LPS (Williams and DuBois, 1996) . Elevated levels of COX-2 have been reported in colon carcinoma tissues (Sano et al., 1995) .
Recently, activation of NF-kB has been shown to be a critical step in COX-2 activation in macrophages exposed to LPS (D'Acquist et al., 1997; Inoue et al., 1998) . Activation of NF-kB involves proteolytic cleavage of I-kB from NF-kB (Baeuerle and Henkel, 1994) . In resting cells, NF-kB is located in the cytoplasm as a heterodimer composed of a 50 kDa (p50) and a 65 kDa (p65) component, both of which are noncovalently associated with the cytoplasmic inhibitor, I-kB. Activation of NF-kB is preceded by phosphorylation of I-kB by I-kB kinase, which is followed by proteolytic removal of I-kB and movement of NF-kB to the nucleus. After this activation and translocation to the nucleus, NF-kB stimulates transcription of target genes including genes for in¯amma-tory cytokines, chemokines, growth factors, cell adhesion proteins, and cytokine receptors. NF-kB also acts as a positive regulator of COX-2 transcription in epithelial cell lines (Newton et al., 1997 (Newton et al., , 1998 . However, the role of NF-kB in activation of colon carcinoma cells after exposure to LPS is not understood.
In this study of the eect of LPS in stimulating a colon carcinoma cell line (CE-1), we found that LPS induced an increase in PGE 2 production that re¯ected an increase in COX-2 expression and NF-kB activation. While LPS activated this speci®c cell line, further work will be needed to assess how generalizable and biologically signi®cant the eects are.
Results

LPS effects on PGE 2 production
We measured the PGE 2 concentration in the supernatant from LPS-stimulated tumor cell cultures to determine whether LPS could induce its production. The three dierent colon carcinoma cell lines, CE-1, DLD-1, and WiDr, each were treated with various doses of LPS for 24 h before concentrations of PGE 2 in supernatants were measured by ELISA. CE-1 cells constitutively secreted PGE 2 , and 100 ng/ml of LPS signi®cantly increased PGE 2 release from CE-1 cells. No increase was seen with DLD-1 or WiDr cells ( Figure 1 ). Next, a kinetic study was carried out to determine the incubation time required for maximal production of PGE 2 . Culture supernatants were collected after 24, 48, and 72 h of incubation with or without LPS (100 ng/ml) to measure the concentration of PGE 2 . A maximal increase in PGE 2 concentration was observed at 24 h after the addition of LPS to CE-1 cells (Figure 2 ). These results indicate that LPS stimulated the production and release of PGE 2 from the CE-1 line.
LPS receptor expression
Because LPS exerts its eect via binding to the LPS receptor on the cell surface, the expression of the highanity LPS receptor, CD14, was examined by¯ow cytometry on the surface of colon carcinoma cells. Analysis of cells showed that CD14 was speci®cally stained on the surfaces of the LPS-responsive CE-1 cells (Figure 3 ), but CD14 was not expressed on the LPS-unresponsive carcinoma cell lines, DLD-1 and WiDr (data not shown). These results suggest that responsiveness of CE-1 cells to LPS is dependent on CD14 expression.
LPS effects on COX-2 expression
As COX-2 is a key enzyme in PGE 2 synthesis, we examined the eect of LPS on COX-2 expression in CE-1, DLD-1, and WiDr cells. Exposure of CE-1 cells to LPS (100 ng/ml) increased COX-2 mRNA levels as demonstrated by RT ± PCR (Figure 4) . The time course of induction of COX-2 mRNA expression was investigated over 8 h of LPS treatment. COX-2 mRNA levels began to increase 3 h after addition of LPS (100 ng/ml) to CE-1 cultures. At 4 h, COX-2 mRNA levels peaked at 3.7 times the control levels. Beyond 4 h, COX-2 mRNA levels decreased signi®cantly to equal the levels in controls. Western blot analysis of /well) were cultured with or without LPS (100 ng/ml) in RPMI medium containing 2% FBS. Supernatants were collected at the times indicated, and PGE 2 levels were measured by ELISA. Cumulative release of PGE 2 is shown; mean+s.e.m. was calculated for triplicate cultures 
LPS-induced NF-kB activation
LPS has been shown to activate NF-kB in macrophages (D'Acquist et al. , 1997; Inoue et al., 1998) . To investigate whether LPS also activates NF-kB in colon carcinomas cells, electrophoretic mobility shift assay (EMSA) was performed. Nuclear protein extracts from unstimulated and LPS-stimulated cells were incubated with a 32 P-labeled oligonucleotide containing a conserved NF-kB binding sequence (see Materials and methods). Figure 6a shows EMSA results in untreated cells and cells treated with LPS for various time intervals. NF-kB was constitutively activated, and LPS upregulated activation of NF-kB in CE-1 cells. Kinetic studies showed that activation levels reached a maximum 3 h after stimulation and then declined. Although NF-kB also was slightly activated in DLD-1 and WiDr cells, LPS did not upregulate nuclear translocation of NF-kB (Figure 6b ). To con®rm the speci®city of binding, competitive studies using a 100-fold excess of unlabeled oligonucleotide were performed. When excess amounts of unlabeled NF-kB probe were added to the mixture, the band intensity was diminished, while adding excess amounts of activation protein-1 (AP-1) probe did not aect binding (Figure 6c ), demonstrating that binding of Figure 4 Semiquantitative RT ± PCR analysis of COX-2 mRNA expression in total RNA extracted from CE-1 cells treated with LPS (100 ng/ml) for the indicated times. The data are presented as a ratio of COX-2 mRNA to HPRT mRNA, calculated from arbitrary densitometry units Oncogene LPS-induced COX-2 in colon carcinoma cells through NF-kB M Kojima et al the NF-kB probe was speci®c. Densitometric analysis of autoradiographic bands showed a maximal LPSinduced NF-kB activation of 2.5 times control levels ( Figure 6d ). NAC has been shown to inhibit the NF-kB activation by LPS in various cell types (Bellezzo et al., 1998; Pahan et al., 1998; Tanaka et al., 1997) . Using NAC we examined its eect on PGE 2 production. NAC (5 mM) signi®cantly reduced PGE 2 production in the LPS-stimulated tumor cells (1300.7+172.9 pg/ml vs 925.0+81.0 pg/ml, P50.05). These results show that activation of NF-kB is a prominent event in stimulation of CE-1 cells by LPS and suggest a correlation between NF-kB and PGE 2 production via COX-2.
PGE 2 effects on cell proliferation
To examine the eect of exogenous PGE 2 on DNA synthesis in CE-1 cells, [ 3 H]thymidine incorporation assays were performed (Figure 7) . DNA synthesis was stimulated with varying concentrations of exogenous PGE 2 , showing increased incorporation that suggested that PGE 2 could be a growth-stimulating factor in CE-1 cells.
Discussion
We report here that LPS directly stimulates a human colon carcinoma cell line (CE-1). Results of this study indicate that LPS increased production of PGE 2 , which acted as a growth factor for these cells. We also showed that LPS upregulated COX-2 mRNA and protein expression, which could account for the increased PGE 2 synthesis by CE-1 cells. LPS-induced PGE 2 production by the tumor cells was found to correlate with NF-kB activation by LPS. Thus, we have demonstrated for the ®rst time that LPS directly activates certain human colon carcinoma cell line, inducing increased PGE 2 synthesis. NF-kB may play a role in this LPS-mediated stimulation. The data presented in this study oer a new perspective on a possible relationship of LPS to colon carcinoma progression.
CD14, mainly expressed on macrophages, is a highanity receptor for LPS. We showed by¯ow cytometry that CD14 was expressed on CE-1 colon carcinoma cells but not on LPS-unresponsive DLD-1 and WiDr cells. The dierence in responsiveness to LPS thus appears to depend on the cell-surface receptor (Figure 8 ). However, this study did not establish that LPS aects CE-1 cells through CD14. Although CD14 is a receptor for LPS/LPS-binding protein, high concentrations of LPS can bind to the cell surface independently of CD14 binding (Brophy and Sibley, 1998) . The speci®c role of CD14 in activation of tumor cells by LPS is under investigation. PGE 2 has been shown to be a growth-promoting factor in certain carcinoma cell lines (Tjandrawinata et al., 1997) , and also recently has been shown to inhibit apoptosis in colon carcinoma cells (Sheng et al., 1998) . PGE 2 suppresses the immune reaction against tumor cells by modulating production of cytokines such as IL-10 and IL-12 by lymphocytes and macrophages (Kucharzik et al., 1997; Huang et al., 1996 Huang et al., , 1998 . Our studies also suggest that LPS may downregulate immunity against tumors in colon cancer patients when it stimulates PGE 2 production by certain colon carcinomas.
The COX enzyme is believed to be a critical step in prostanoid synthesis, and prominent inducible COX-2 expression has been found in gastrointestinal and lung tumors (Sano et al., 1995; Eberhart et al., 1994; Kargman et al., 1995; Ristimaki et al., 1997; Hida et al., 1998; Wol et al., 1998) . COX-2 also has been linked to colon carcinogenesis (Oshima et al., 1996; Gustafson-Svard et al., 1996) , and its overexpression may alter the biologic behavior of tumor cells in various ways Tsuji and DuBois, 1995) . Recent studies have suggested that COX-2 regulates metastasis and angiogenesis in colon carcino- Figure 7 Growth-stimulating eect of exogenous PGE 2 on CE-1 cells. Cells were cultured in 96-well microplates (2610 4 cells/well) in the presence or absence of PGE 2 (5 ± 5000 ng/ml) for 68 h, after which [ 3 H]thymidine was then added and cells were incubated for an additional 12 h. Cells were harvested and incorporated radioactivity was measured with a scintillation counter. *Signi®cantly dierent from untreated cells (P50.05) Figure 8 Possible scheme of diering mechanisms of COX-2 expression and PGE 2 production in colon carcinoma cells. In CE-1 cells (left), which possess LPS receptors, LPS induces NF-kB activation dramatically, then increasing COX-2 mRNA and PGE 2 synthesis. In DLD-1 and WiDr cells (right), which have very few LPS receptors, only endogenous activation of NF-kB is associated with COX-2 expression LPS-induced COX-2 in colon carcinoma cells through NF-kB M Kojima et al ma (Tsuji et al., 1997 (Tsuji et al., , 1998 . Although COX-2 expression appears to participate in tumor proliferation and progression, few reports have examined modulation of COX-2 expression in carcinoma cells by external factors. Tjandrawinata et al. (1997) have shown that exogenous PGE 2 increased COX-2 mRNA expression in human prostatic carcinoma, and Huang et al. (1998) have demonstrated COX-2 induction by IL-1b in non-small cell lung cancer cells. LPS has been shown to regulate COX-2 in nonneoplastic cells, such as macrophages (Lee et al., 1992) , but our ®nding that LPS can modulate COX-2 expression in a line of carcinoma cells represents a new avenue of investigation. When a colon carcinoma is exposed to large amounts of LPS, tumor progression might result from COX-2 overexpression. Mechanisms underlying elevated COX-2 expression in tumor cells may involve activation of oncogenes or inactivation of anti-oncogenes (Oshima et al., 1996; Subbaramaiah et al., 1996; Sheng et al., 1997) . Although NF-kB has been shown to be involved LPS eects on COX-2 in macrophages (D'Acquist et al., 1997; Inoue et al., 1998) , the role of NF-kB activation in LPS-stimulated colon carcinoma cells remains unclear. We demonstrated that LPS activated NF-kB in CE-1 colon carcinoma cells concomitantly with increased COX-2 expression. Our recent studies have shown that colon carcinoma tissue in surgical resection specimens shows greater activation of NF-kB than nearby nonneoplastic tissue (data unpublished). NF-kB has a wide range of eects. Above all, NF-kB is shown to regulate several genes, such as ICAM-1, ELAM-1, and matrix metalloproteinase-9, that are involved in tumor progression and metastasis (Sato and Seiki, 1993; Ikebe et al., 1998; Jahnke and Johnson, 1994; Wissink et al., 1998; Collins et al., 1995) . Activation of NF-kB in tumor cells may be associated with malignant potential (Raziuddin et al., 1997) . Giri et al. (1998) recently have demonstrated that NF-kB activation in HuT-78 T-cell lymphoma cells was related to a reduction in apoptosis. A selective inhibitor of COX2 might inhibit carcinogenesis or tumor proliferation, and might be useful for chemoprevention of colon carcinoma (Sheng et al., 1997a,b; Reddy et al., 1996) . Regulation of NF-kB activation in colon carcinoma may also oer new strategies for arresting tumor progression or for chemoprevention.
In conclusion, we demonstrated that exogenous LPS directly stimulated the CE-1 line of human colon carcinoma cells to produce PGE 2 , which may act as an autocrine growth-stimulating factor. Increases in COX-2 expression and NF-kB activation were associated with increased PGE 2 production. Direct activation of certain carcinoma cells by in vitro by a bacterial product, LPS, suggest that tumor cells may be activated by exposure to colonic¯ora or by endotoxemia.
Materials and methods
Tumor cells and reagents
The human colon adenocarcinoma CE-1 cell line was established in our laboratory from a surgical resection specimen. Cells were maintained in RPMI-1640 medium (Sanko Pure Chemicals, Tokyo, Japan) supplemented with 10% fetal bovine serum (FBS, Filtron Pty. Ltd., Australia) and antibiotics (100 U/ml penicillin and 100 mg/ml streptomycin) at 378C. Two other human colon carcinoma cell lines, DLD-1 and WiDr, were obtained from the American Type Culture Collection (Rockville, MD, USA). LPS (from Escherichia coli 0111: B4) was purchased from Difco Laboratories (Detroit, MI, USA). Recombinant PGE 2 was purchased from Cayman Chemical (Ann Arbor, MI, USA). N-acetyl cysteine (NAC) was purchased from Sigma Chemical (St. Louis, MO, USA).
Measurement of PGE 2
CE-1, DLD-1, and WiDr cells were seeded in 24-well plates (5610 5 cells/well), incubated in RPMI with 2% FBS and diering concentrations of LPS for various times, after which the culture supernatant was collected to measure PGE 2 concentration using a monoclonal antibody in an enzymelinked immunosorbent assay (ELISA) kit as speci®ed by the manufacturer (Cayman Chemical). The limit of sensitivity for detection of PGE 2 was 10 pg/ml.
Flow cytometric analysis
Aliquots containing 10 6 cells were stained with FITCconjugated anti-CD14 monoclonal antibody (Becton Dickinson, San Jose, CA, USA). Cells were washed three times with PBS, and¯uorescence intensity was measured by a FACSCalibur¯ow cytometer (Becton Dickinson). Calculations involved in measurement of¯uorescence were performed automatically by a computer. Background uorescence was determined using FITC conjugated isotype-matched antibody against human IgG.
Semiquantitative RT ± PCR
RT ± PCR ampli®cation and analysis of COX-2 mRNA was performed in the three colon carcinoma cell lines after incubation with LPS (100 ng/ml) for varying periods. Total RNA was extracted from samples using a guanidinium thiocyanate phenol extraction method as described previously (Chomcyznski and Saachi, 1987) . Total RNA (1 mg) was converted to cDNA using a Superscript II kit (Life Technologies, Inc., Rockville, MD, USA) with random hexamers (Life Technologies, Inc.). To assess the amount of COX-2-speci®c mRNA, PCR was performed from the cDNA samples for COX-2 and for a constitutively expressed housekeeping gene coding for the enzyme hypoxanthine phosphoribosyltransferase (HPRT). PCR products were ampli®ed in proportion to the PCR cycles at ten to 50 cycles, but at more than 45 cycles, the curve of changes signi®cantly to indicate a much slower rate of increase. Therefore, we selected 35 cycles for PCR detection of COX-2 and HPRT mRNA expression. Oligonucleotide primers were: COX-2, 5'-TTCAAATGAGATTGTGGGAAAAT-3' (sense) and 5'-AGATCATCTCTGCCTGAGTATCTT-3' (antisense); and HPRT, 5'-CGAGATGTGATGAAGGAGATGG-3' (sense) and 5'-GGATTATACTGCCTGACCAAGG-3' (antisense) (O'neil and Ford-Hutchinson, 1993; Jolly et al., 1983) . PCR products were separated by electrophoresis on 1.5% agarose gels and stained with ethidium bromide. For quantitation, photographs of gels were scanned with a Scan Jet 4C/T (Hewlett Packard, San Diego, CA, USA), and densitometry was performed using the NIH Image Program (version 1.60; NIH Division of Computer Research and Technology, Bethesda, MD, USA) on a Macintosh personal computer (Apple Computer, Inc., Cupertino, CA, USA). COX-2 mRNA expression then was normalized to corresponding HPRT mRNA expression.
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Western blot analysis
Immunoblotting analysis of COX-2 protein was performed as described previously with slight modi®cations (Suh et al., 1998) using colon carcinoma cell lines. After LPS treatment, cells were suspended in lysis buer [10 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.1% SDS, 0.1% sodium deoxycholate, 1% NP40, 1 mM EDTA, and 10 mg/ml aprotinin], and the protein concentration was determined by the method of Bradford (Bio-Rad, Hercules, CA, USA). Equal amounts of protein (50 mg) were loaded in each lane and separated by SDS ± PAGE (12% acrylamide). The proteins were transferred onto nitrocellulose membranes according to the manufacturer's instructions (Hybond ECL; Amersham, Buckinghamshire, UK). The membranes were blocked by incubation at 48C overnight with 10% nonfat dry milk in PBS, and then incubated with anti-COX-2 antibody (1 : 1000; Cayman Chemical) for 1 h at room temperature. The membranes were washed three times with 1% Triton X-100 in PBS and stained with peroxidase-conjugated secondary antibody (1 : 1000). The peroxidase conjugate was visualized by the ECL method (Amersham). Densitometric quantitation of blots was performed as described above.
Electrophoretic Mobility Shift Assay (EMSA)
NF-kB activity in nuclei isolated from colon carcinoma cells was determined by EMSA. Extraction of nuclear proteins and EMSA were carried out as described previously (Izuhara et al., 1996) . Brie¯y, 5 mg of nuclear proteins were incubated for 30 min at room temperature with binding buer [20 mM HEPES-NaOH (pH 7.9), 2 mM EDTA, 100 mM NaCl 10% glycerol, 0.2% NP-40], poly(dI-dC), and 32 P-labeled doublestranded oligonucleotide containing the NF-kB binding motif (Promega Corp, Madison, WI, USA). Sequences of the double-stranded oligomers used for EMSA were as follows: 5'-AGTTGAGGGGACTTTCCCAGGC-3'. The reaction mixtures were loaded on a 4% polyacrylamide gel and electrophoresed with a running buer of 0.256TBE. After the gel was dried, the DNA-protein complexes were visualized by autoradiography. We used AP-1 probe (Promega Corp) in competitive studies. Sequences of AP-1 probe were as follows: 5'-CGCTTGATGAGTCAGCCG-GAA-3'.
Cell proliferation assay
To analyse the growth of cells in the presence of PGE 2 , a standard [ 3 H]thymidine incorporation assay was set up in 96-well round-bottomed microplates as described previously (Morisaki et al., 1992) . CE-1 cells were seeded in wells at 2610 4 cells/well in 200 ml of culture media containing various concentrations of PGE 2 , incubated for 68 h, after which [ 3 H]thymidine was added to each well (0.5 mCi/well). The plate was incubated for an additional 12 h. Cells were harvested with a cell harvester (LKB-Wallac, Turku, Finland), and radioactivity was measured in a scintillation counter (LKB-Wallac). Analysis of cell proliferation at dierent concentrations of PGE 2 was carried out in triplicate.
Statistics
Results are expressed as the mean+s.e.m. Statistical signi®cance was determined by Student's t-test, with P5 0.05 considered signi®cant.
Abbreviations LPS, lipopolysaccharide; PG, prostaglandin; COX, cyclooxygenase, NF-kB, nuclear factor-kB; RT ± PCR, reverse transcription-polymerase chain reaction.
